Eagle Global Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Eagle Global Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,250	Closed	-$206K	–	238
2018 Q1	$206K	Sell	3,250 -1,215	-27%	-$78.2K	0.01%	232
2017 Q4	$274K	Hold	4,465	–	–	0.01%	218
2017 Q3	$285K	Sell	4,465 -4,155	-48%	-$243K	0.01%	210
2017 Q2	$480K	Buy	+8,620	New	+$469K	0.01%	227
2017 Q1	–	Sell	-4,300	Closed	-$251K	–	389
2016 Q4	$251K	Hold	4,300	–	–	0.01%	294
2016 Q3	$232K	Sell	4,300 -200	-4%	-$12.8K	0.01%	296
2016 Q2	$331K	Hold	4,500	–	–	0.01%	249
2016 Q1	$287K	Hold	4,500	–	–	0.01%	272
2015 Q4	$310K	Hold	4,500	–	–	0.01%	271
2015 Q3	$266K	Hold	4,500	–	–	0.01%	290
2015 Q2	$299K	Hold	4,500	–	–	0.01%	288
2015 Q1	$290K	Hold	4,500	–	–	0.01%	258
2014 Q4	$266K	Sell	4,500 -448	-9%	-$25.3K	0.01%	274
2014 Q3	$253K	Hold	4,948	–	–	0.01%	276
2014 Q2	$240K	Hold	4,948	–	–	0.01%	273
2014 Q1	$257K	Buy	4,948 +448	+10%	+$23.8K	0.01%	244
2013 Q4	$239K	Hold	4,500	–	–	0.01%	221
2013 Q3	$208K	Hold	4,500	–	–	0.01%	226
2013 Q2	$201K	Buy	+4,500	New	+$195K	0.01%	218

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Eagle Global Advisors's BMY Position: Q2 2018 in Review

Eagle Global Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2018, closing a stake of 3,250 shares — an estimated $206K sold.

Eagle Global Advisors first reported a position in BMY in Q2 2013 and held it in 19 quarters. The position peaked at $480K in Q2 2017. 1,691 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

Eagle Global Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2018 after selling out during the quarter.
Eagle Global Advisors sold 3,250 Bristol-Myers Squibb shares in Q2 2018, an estimated $206K.
Eagle Global Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 19 quarters.
Eagle Global Advisors's Bristol-Myers Squibb position peaked at $480K in Q2 2017.
1,691 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on Eagle Global Advisors's 13F filing for Q2 2018, filed 1 Aug 2018.